trial · primary record
89Zr-DFO-SC16.56
Small Cell Lung Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 105 |
| Primary completion | 2027-06-11 |
| Primary endpoint | Phase I: Radiation Dosimetry of 89Zr- DFO-SC16.56 PET/CT imaging in participants |
| Registry ID | NCT04199741 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:14.293Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04199741
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.